Research Triangle Park, NC, December 10, 2009 --(PR.com
)-- CED, formerly the Council for Entrepreneurial Development (www.cednc.org), a private, nonprofit organization that promotes entrepreneurial efforts in the Triangle region of North Carolina, has announced that it will offer new programming for CED’s Biotech 2010 conference. CED will present its 19th annual Biotech conference Monday, Feb. 22 through Tuesday, Feb. 23, 2010, at the Raleigh Convention Center, located at 500 South Salisbury Street. The premier life science event will feature keynotes such as Steve Krognes, senior vice president and chief financial officer for Genentech, Inc. and Louis Lange, M.D., Ph.D., executive vice president of Cardiovascular Therapeutics at Gilead Sciences, Inc.
“CED has introduced these new program offerings as a result of continued support from our biotechnology community, as evidenced by our record-breaking 1,000 attendee crowd at Biotech 2009,” said CED president Joan Siefert Rose. “We plan to exceed our attendees’ expectations again this year.”
New Media Content:
CED Twitter page
- Biotech 2010 will be presented by CED in partnership with the North Carolina Biotechnology Center (www.ncbiotech.org) and North Carolina Biosciences Organization (www.ncbioscience.org). The conference will focus on pharmaceutical partnering, personalized medicine and global health. Keynote speakers include: Ernest Mario, Ph.D., chairman and CEO, Capnia; Steve Krognes, senior vice president and chief financial officer, Genentech, Inc.; Louis G. Lange, M.D., Ph.D., executive vice president, Cardiovascular Therapeutics, of Gilead Sciences, Inc.; and Allen D. Roses, MD, FRCP, director, Deane Drug Discovery Institute, Duke University.
- Biotech 2010 will feature two new program offerings: The North Carolina Biotechnology Center will host partnering meetings, designed for emerging biotech companies to match with leading pharmaceutical companies. More information and registration is available at www.cednc.org/partnering. Additionally, Hoffman-La Roche Inc. will host Venture Day, a chance for an investor-only audience to take a look at the new drug development business model.
- Biotech 2010 will feature expert panels on topics such as pharmaceutical partnering, personalized medicine and the current funding environment.
- CED is offering early bird registration rates for Biotech 2010 until Wednesday, January 20. For more information on the early bird rates, visit http://cednc.org/content/registration/380.
- As part of a new promotion, CED is offering existing and new members a $50 discount when registering for Biotech 2010 or Venture 2010 if they renew their membership or join CED at the same time. For more information or to take advantage of CED’s promotion, contact Lilith Anderson, CED’s associate director of development at (919) 226-0468 or e-mail email@example.com.
CED (formerly The Council for Entrepreneurial Development) is a private, nonprofit organization founded in 1984 to identify, enable and promote high-growth, high-impact companies and accelerate the region’s entrepreneurial culture. Headquartered in the Research Triangle Park, CED is the oldest and largest entrepreneurial support organization in the nation with more than 5,500 active members. CED provides know-how, networking, mentoring and capital formation resources to new and existing high-growth entrepreneurs through annual conferences, programs and web-based resources. CED has helped entrepreneurs, investors, service partners, researchers and public policy makers in diverse emerging industries and at all stages of development – from high-tech, production-based organizations to service companies, from one-person start-ups to 1000-person businesses. Visit www.cednc.org for more information.
MMI Public Relations